We specialize in promoting medical innovations. That’s why we know: Life science startups have to overcome higher hurdles than startups from other industries. At the same time, however, there are rarely experts in these critical areas in the founding…
OMT-28’s established safety profile, biomarker data, and funding secured from existing investors enable swift transition into a Phase II clinical study
Diverse challenges and opportunities
The Berlin-Brandenburg capital region is one of the leading life science regions in Europe and a lot is being done to keep it that way: with a wide variety of space offerings and support program for founders and start-ups.
Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Germany and the UK, have found that a commonly used liver drug also affects infection with the SARS-CoV-2 coronavirus. It causes the number of ACE-2…
Prestigious commendation
Max Planck Director Prof. Dr. Peter Fratzl has been appointed honorary life member by the Chinese Chemical Society (CCS). The CCS describes this nomination as "the highest honor bestowed on the world's most distinguished…
Ulrike Stein is searching for molecules that play a key role in metastasis, aiming to use them as therapeutic targets for solid tumors and to improve cancer prognosis. The Metastasis Research Society has recognized her work with this year’s Women in…
In the human body, electrolytes play a key role in maintaining water balance and distribution of fluids. All charged particles dissolved in the blood interact with each other. If a disturbance to their complex equilibrium is suspected, the…
First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed. It is still unclear exactly how, when and where this virus originated. Now, a study published in the journal…
• New collaboration builds on encouraging clinical data previously reported from INSIGHT-004 in multiple
solid tumour indications from the combination of eftilagimod alpha (“efti”) and avelumab (BAVENCIO®)
• Expansion into urothelial cancer builds…
